EcoDrugPlus

Ensembl ID : ENSCHYG00000013420
Gene Symbol: -
Cross references: -
239 Possible Orthologues:

Ensembl ID : ENSCHYG00000010877
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSCHYG00000010736
Gene Symbol: -
Cross references: -
317 Possible Orthologues:

Ensembl ID : ENSCHYG00000010727
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSCHYG00000008953
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSCHYG00000008418
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Ensembl ID : ENSCHYG00000008363
Gene Symbol: -
Cross references: -
237 Possible Orthologues:

Ensembl ID : ENSCHYG00000008294
Gene Symbol: -
Cross references: -
271 Possible Orthologues:

Ensembl ID : ENSCHYG00000003273
Gene Symbol: -
Cross references: -
66 Possible Orthologues:

Ensembl ID : ENSCHYG00000001416
Gene Symbol: -
Cross references: -
225 Possible Orthologues:

Ensembl ID : ENSCHYG00000001155
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSCHYG00000001110
Gene Symbol: -
Cross references: -
271 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).